{"id":"W2549580878","doi":"10.1182/blood.v126.23.28.28","title":"Eloquent-2 Update: A Phase 3, Randomized, Open-Label Study of Elotuzumab in Combination with Lenalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma - 3-Year Safety and Efficacy Follow-up","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Multiple myeloma; Refractory (planetary science); Oncology; Internal medicine; Phases of clinical research; Daratumumab; Clinical trial; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003336716,0.00143977,0.00274192,0.0005143132,0.0003900548,0.001559749,0.00122438,0.001681361,0.003893598],"category_scores_gemma":[0.001415144,0.0006109858,0.002759623,0.0005874621,0.0006898758,0.001031134,0.000350659,0.002833564,0.0009291486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001207411,"about_ca_system_score_gemma":0.001321339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001096311,"about_ca_topic_score_gemma":0.003813601,"domain_scores_codex":[0.9990802,0.0004886038,0.0000611637,0.0001288868,0.0001367112,0.0001043492],"domain_scores_gemma":[0.9991153,0.0002043937,0.0002711422,0.00006322956,0.0001110656,0.0002347734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.76187,0.01593669,0.00741418,0.002915117,0.007366262,0.0003269035,0.0002106706,0.001713553,0.01559059,0.0004723908,0.01235936,0.1738242],"study_design_scores_gemma":[0.887772,0.08211046,0.01449641,0.000168702,0.002551821,0.0003478974,0.00004821349,0.0008438912,0.001399231,0.0002666147,0.009941084,0.00005379003],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9227617,0.04246985,0.002529653,0.003907479,0.0007687432,0.007612736,0.01241791,0.0005203849,0.0070115],"genre_scores_gemma":[0.9338076,0.01773208,0.006366036,0.007966051,0.0009675872,0.008473426,0.01844009,0.0001463161,0.006100907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003893598,"threshold_uncertainty_score":0.01764643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03183983250104835,"score_gpt":0.3103030056244102,"score_spread":0.2784631731233618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}